These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 3196008
1. In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains. Smith RP, Baltch AL, Hammer MC, Conroy JV. Antimicrob Agents Chemother; 1988 Sep; 32(9):1450-5. PubMed ID: 3196008 [Abstract] [Full Text] [Related]
9. Antimicrobial activity of DV-7751a, a new fluoroquinolone. Tanaka M, Hoshino K, Ishida H, Sato K, Hayakawa I, Osada Y. Antimicrob Agents Chemother; 1993 Oct; 37(10):2112-8. PubMed ID: 8257132 [Abstract] [Full Text] [Related]
10. [Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002]. Matsuzaki K, Watabe E, Yoshimori K, Shikano M, Sato Y, Hasegawa M, Kobayashi I. Jpn J Antibiot; 2002 Dec; 55(6):800-7. PubMed ID: 12621734 [Abstract] [Full Text] [Related]
11. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria. Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB. Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163 [Abstract] [Full Text] [Related]
12. In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency. Huband MD, Cohen MA, Meservey MA, Roland GE, Yoder SL, Dazer ME, Domagala JM. Antimicrob Agents Chemother; 1993 Dec; 37(12):2563-70. PubMed ID: 8109918 [Abstract] [Full Text] [Related]
13. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics. Chin NX, Neu HC. J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856 [Abstract] [Full Text] [Related]
14. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections. Bongaerts GP, Hoogkamp-Korstanje JA. Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624 [Abstract] [Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y, Hirose T, Yokoo A, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Kitagawa R, Igari J, Oguri T, Kosakai N, Yamaguchi K, Kashitani F, Yonezu S, Yamanaka Y, Takaha M, Iori F. Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [Abstract] [Full Text] [Related]
17. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C. Drugs Exp Clin Res; 1998 May; 24(3):139-51. PubMed ID: 9825230 [Abstract] [Full Text] [Related]
18. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. McCarter YS, Mazens-Sullivan MF, Bartlett RC. Chemotherapy; 1992 May; 38(5):308-18. PubMed ID: 1337507 [Abstract] [Full Text] [Related]
19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution]. Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C. Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437 [Abstract] [Full Text] [Related]
20. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Marshall SA, Jones RN. Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]